Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Dale H. Conaway currently holds 379,177 shares of Boston Therapeutics, Inc. (BTHE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Dale H. Conaway has been a net buyer of BTHE stock. They have purchased $5.9K and sold $0 worth of shares.
Dale H. Conaway's most recent insider trade was on Nov 14, 2025, when they sold 38,588 shares at $0.35 per share.
Dale H. Conaway serves as Executive at Boston Therapeutics, Inc. (BTHE). They have executed 27 insider transactions totaling $5.9K over their tenure at the company.
Dale H. Conaway holds the position of Executive at Boston Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Dale H. Conaway has shown a buying trading pattern, with $5.9K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Dale H. Conaway was on Aug 19, 2024, when they sold $180.2K worth of BIXT shares. This transaction involved 1,060,089 shares at $0.17 per share.
Dale H. Conaway currently owns 379,177 shares of Boston Therapeutics, Inc. (BTHE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Dale H. Conaway's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Dale H. Conaway has 27 Form 4 filings on record as an insider at Boston Therapeutics, Inc..
Set alerts for Dale H. Conaway and 40,000+ other insiders.